Back to Journals » Drug Design, Development and Therapy » Volume 12

Review

Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer

       
Total article views   HTML views PDF downloads Totals
32,096 Dovepress* 19,796+ 2,803 22,599
PubMed Central* 12,300 2,034 14,334
Totals 32,096 4,837 36,933
*Since 16 February 2018
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 1 6

View citations on PubMed and Google Scholar